Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/9022
DC FieldValueLanguage
dc.contributor.authorAbizaid, Alexandreen_US
dc.contributor.authorKedev Saskoen_US
dc.contributor.authorKedhi, Elvinen_US
dc.contributor.authorTalwar, Suneelen_US
dc.contributor.authorErglis, Andrejsen_US
dc.contributor.authorHlinomaz, Otaen_US
dc.contributor.authorMasotti, Monicaen_US
dc.contributor.authorFath-Ordoubadi, Farzinen_US
dc.contributor.authorLemos, Pedro Aen_US
dc.contributor.authorMilewski, Krzysztofen_US
dc.contributor.authorBotelho, Robertoen_US
dc.contributor.authorCosta, Ricardoen_US
dc.contributor.authorBangalore, Sripalen_US
dc.date.accessioned2020-09-14T08:45:40Z-
dc.date.available2020-09-14T08:45:40Z-
dc.date.issued2018-12-07-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/9022-
dc.description.abstractThe aim of this study was to evaluate the safety and efficacy of the BioMime sirolimus-eluting coronary stent (SES) compared to the XIENCE family of everolimus-eluting coronary stents (EES) in the treatment of patients with de novo native coronary artery lesions.en_US
dc.language.isoenen_US
dc.relation.ispartofEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiologyen_US
dc.titleRandomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trialen_US
dc.typeArticleen_US
dc.identifier.doi10.4244/EIJ-D-18-00762-
dc.identifier.volume14-
dc.identifier.issue11-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Прикажи едноставен запис

Page view(s)

322
checked on 19.7.2025

Google ScholarTM

Проверете

Altmetric


Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.